Ronilda R D'Cunha (Ronilda D'Cunha)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Diffusion Weighted

Pulmonary Artery

Top Venues

Clinical and translational science

Science translational medicine

Clinical pharmacology and therapeutics

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yinuo Pang, Ronilda R D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace
Risankizumab: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Michael J McPherson, Adrian D Hobson, Axel Hernandez, Christopher C Marvin, Wendy Waegell, Christian Goess, Jason Z Oh, Dan Shi, Martin E Hayes, Lu Wang, Lu Wang, Diana Schmidt, Zhi Wang, Victoria Pitney, Kimberley McCarthy, Ying Jia, Ce Wang, Bit Na Kang, Shaughn Bryant, Suzanne Mathieu, Melanie C Ruzek, Julie Parmentier, Ronilda R D'Cunha, Yinuo Pang, Lucy Phillips, Nathan J Brown, Jianwen Xu, Candace Graff, Yu Tian, Kenton L Longenecker, Wei Qiu, Haizhong Zhu, Wei Liu, Pingping Zheng, Yingtao Bi, Robert Stoffel
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases. Science translational medicine 16 (739) (2024)
Yinuo Pang, Ronilda R D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace
Risankizumab: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Yinuo Pang, Ronilda R D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace
Risankizumab: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics 116 (3) (2024)
Michael J McPherson, Adrian D Hobson, Axel Hernandez, Christopher C Marvin, Wendy Waegell, Christian Goess, Jason Z Oh, Dan Shi, Martin E Hayes, Lu Wang, Lu Wang, Diana Schmidt, Zhi Wang, Victoria Pitney, Kimberley McCarthy, Ying Jia, Ce Wang, Bit Na Kang, Shaughn Bryant, Suzanne Mathieu, Melanie C Ruzek, Julie Parmentier, Ronilda R D'Cunha, Yinuo Pang, Lucy Phillips, Nathan J Brown, Jianwen Xu, Candace Graff, Yu Tian, Kenton L Longenecker, Wei Qiu, Haizhong Zhu, Wei Liu, Pingping Zheng, Yingtao Bi, Robert Stoffel
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases. Science translational medicine 16 (739) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics (2024)
Michael J McPherson, Adrian D Hobson, Axel Hernandez, Christopher C Marvin, Wendy Waegell, Christian Goess, Jason Z Oh, Dan Shi, Martin E Hayes, Lu Wang, Lu Wang, Diana Schmidt, Zhi Wang, Victoria Pitney, Kimberley McCarthy, Ying Jia, Ce Wang, Bit Na Kang, Shaughn Bryant, Suzanne Mathieu, Melanie C Ruzek, Julie Parmentier, Ronilda R D'Cunha, Yinuo Pang, Lucy Phillips, Nathan J Brown, Jianwen Xu, Candace Graff, Yu Tian, Kenton L Longenecker, Wei Qiu, Haizhong Zhu, Wei Liu, Pingping Zheng, Yingtao Bi, Robert Stoffel
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases. Science translational medicine 16 (739) (2024)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science (2023)
Ronilda R D'Cunha, Hartmut Kupper, Dilek Arikan, Weihan Zhao, David Carter, Jonas Blaes, Melanie Ruzek, Yinuo Pang
A first-in-human study of the novel immunology antibody drug conjugate, ABBV-3373, in healthy participants. British journal of clinical pharmacology (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science (2023)
Mohamed-Eslam F Mohamed, Yuli Qian, Ronilda R D'Cunha, Teresa Sligh, Laura K Ferris, Ann Eldred, Gweneth F Levy, Shuai Hao, Shashikanth Gannu, David G Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Clinical and translational science 17 (1) (2023)
Neha Thakre, Ronilda R D'Cunha, Aline Goebel, Wei Liu, Yinuo Pang, Ahmed A Suleiman
Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis. Rheumatology and therapy 9 (6) (2022)